Twist Bioscience Corporation
NASDAQ:TWST
45.52 (USD) • At close November 7, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Twist Bioscience Corporation |
Symbool | TWST |
Munteenheid | USD |
Prijs | 45.52 |
Beurswaarde | 2,666,834,720 |
Dividendpercentage | 0% |
52-weken bereik | 15.85 - 60.9 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Dr. Emily Marine Leproust Ph.D. |
Website | https://www.twistbioscience.com |
An error occurred while fetching data.
Over Twist Bioscience Corporation
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)